购物车
- 全部删除
- 您的购物车当前为空
NP-313 (NSC-4264) 是一种有效的抗血栓剂,对血栓素 A 2 合成和选择性抑制由 SOCC 介导的 Ca 2+ 内流有抑制作用,可以抑制血小板的聚集和活化。
为众多的药物研发团队赋能,
让新药发现更简单!
NP-313 (NSC-4264) 是一种有效的抗血栓剂,对血栓素 A 2 合成和选择性抑制由 SOCC 介导的 Ca 2+ 内流有抑制作用,可以抑制血小板的聚集和活化。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 497 | 现货 | |
5 mg | ¥ 1,230 | 现货 | |
10 mg | ¥ 1,980 | 现货 | |
25 mg | ¥ 3,910 | 现货 | |
50 mg | ¥ 5,590 | 现货 | |
100 mg | ¥ 7,820 | 现货 | |
500 mg | ¥ 15,600 | 现货 |
产品描述 | NP-313 (NSC-4264) is a potent antithrombotic agent that inhibits platelet aggregation and activation by inhibiting thromboxane A 2 synthesis and selectively inhibiting SOCC-mediated Ca2+ efflux. |
靶点活性 | TXA2:3.9 µM, COX-1:1.5 µM |
体外活性 | NP-313 (0-80 μM) can inhibit platelet aggregation in a dose-dependent manner. Among them, NP-313 can inhibit thrombin- and A23187-induced platelet aggregation to a maximum extent of about 80% and 60%, respectively.[1] NP-313 (0-8 μM) concentration-dependently inhibits P-selectin expression and collagen- or thrombin-induced thromboxane B 2 (TXB2) production in human platelets. Meanwhile, NP-313 inhibits COX-1 and TXA 2 synthase with IC50 values of 1.5 and 3.9 µM, respectively.[1] |
体内活性 | NP-313 (4-16 µg/g; i.v.) significantly prolongs time-to-occlusion (TTO), prolongs bleeding time, and inhibits platelet aggregation induced by collagen (10 µg/mL) in male ICR mice.[1] |
别名 | NSC-4264, NSC4264, NSC 4264, NP 313 |
分子量 | 249.65 |
分子式 | C12H8ClNO3 |
CAS No. | 5397-78-4 |
Smiles | O=C1C=2C(C(=O)C(Cl)=C1NC(C)=O)=CC=CC2 |
密度 | 1.44g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 60 mg/mL (240.34 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容